Page last updated: 2024-08-05 15:43:21

EC 1.14.14.154 (sterol 14alpha-demethylase) inhibitor

Any EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor that interferes with the action of sterol 14alpha-demethylase (EC 1.14.14.154).

ChEBI ID: 143828

Members (1)

MemberDefinitionClass
ravuconazoleA member of the class of triazoles that is 1-butyl-1H-1,2,4-triazole in which the butyl group is substituted at positions 2, 2, and 3 by hydroxy, 2,4-difluorophenyl, and 4-(p-cyanophenyl)-1,3-thiazol-2-yl groups, respectively (the R,R stereoisomer). It exhibits antifungal activity by inhibition of 14alpha demethylase, an enzyme involved in sterol synthesis, resulting in lysis of the fungal cell wall and fungal cell death. (NCIO4)ravuconazole

Research

Studies (121)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-19900 (0.00)18.7374
1990's12 (9.92)18.2507
2000's61 (50.41)29.6817
2010's27 (22.31)24.3611
2020's21 (17.36)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials7 (5.60%)5.53%
Reviews15 (12.00%)6.00%
Case Studies4 (3.20%)4.05%
Observational0 (0.00%)0.25%
Other99 (79.20%)84.16%

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Cytochrome P450 3A4Homo sapiens (human)IC501.010011
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)IC5010.370011